Deep sequencIng in Cutaneous Squamous CEll caRciNomas
Status:
Not yet recruiting
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
To comprehensively describe the molecular profile of the tumour ecosystem of cutaneous
squamous cell carcinoma (CSCC) patients treated with neoadjuvant immunotherapy using
single-cell sequencing and bulk genomic profiling.
Phase:
Phase 2
Details
Lead Sponsor:
Peter MacCallum Cancer Centre, Australia
Collaborators:
Monash University Regeneron Pharmaceuticals Sanofi University of Adelaide University of Melbourne